IDEAYA Biosciences (IDYA) Profit After Tax (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Profit After Tax of -$98.5 million for Q1 2026, down 38.0% on a YoY basis from -$158.9 million in Q1 2025, and down 16.6% sequentially from -$84.5 million in Q4 2025.
IDEAYA Biosciences (IDYA) Profit After Tax (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Profit After Tax data on file, last reported at -$98.5 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 38.0% year-over-year to -$98.5 million; the trailing twelve-month figure through Mar 2026 stood at -$140.8 million (up 54.57% YoY), and the FY2025 full-year result was -$113.7 million, up 58.54% from the prior year.
- Profit After Tax declined to -$98.5 million in Q1 2026, from -$84.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $119.8 million in Q3 2025 to a low of -$133.3 million in Q4 2024.
- A 5-year average of -$38.7 million and a median of -$34.0 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 2309.34% in 2023 and surged 331.13% in 2025, its largest moves.
- Tracing IDYA's Profit After Tax over 5 years: stood at -$20.9 million in 2022, then slumped by 62.38% to -$34.0 million in 2023, then tumbled by 292.68% to -$133.3 million in 2024, then surged by 36.62% to -$84.5 million in 2025, then retreated by 16.6% to -$98.5 million in 2026.
- Business Quant data shows IDYA's Profit After Tax at -$98.5 million in Q1 2026, -$84.5 million in Q4 2025, and $119.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -98.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.54 Mn |
| Dec 31, 2025 | -84.51 Mn |
| Sep 30, 2025 | 119.78 Mn |
| Jun 30, 2025 | -77.49 Mn |
| Mar 31, 2025 | -71.41 Mn |
| Dec 31, 2024 | -133.34 Mn |
| Sep 30, 2024 | -51.82 Mn |
| Jun 30, 2024 | -53.27 Mn |
| Mar 31, 2024 | -39.57 Mn |
| Dec 31, 2023 | -33.96 Mn |
| Sep 30, 2023 | -27.44 Mn |
| Jun 30, 2023 | -27.70 Mn |
| Mar 31, 2023 | -23.64 Mn |
| Dec 31, 2022 | -20.91 Mn |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | -22.06 Mn |
| Mar 31, 2022 | -14.01 Mn |
| Dec 31, 2021 | -18.21 Mn |
| Sep 30, 2021 | -11.63 Mn |
| Jun 30, 2021 | -10.95 Mn |